Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Hagemann, Carsten ^a   Anacker, Jelena ^a   Haas, Stefanie ^b   Riesner, Daniela ^a   Schömig, Beate ^a   Ernestus, Ralf Ingo ^a   Vince, Giles H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149249591     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-293     Document Type: Article

References (61)

1. Pathology and molecular genetics of astrocytic gliomas. G Reifenberger VP Collins, J Mol Med 2004 82 656 670 10.1007/s00109-004-0564-x 15316624
2. Molecular mechanisms of glioma cell migration and invasion. T Demuth ME Berens, J Neur-Oncol 2004 70 217 228 10.1007/s11060-004-2751-6 (Pubitemid 39545733)
3. Genetic pathways to glioblastoma: a population-based study. H Ohgaki P Dessen B Jourde S Horstmann T Nishikawa PL DiPatre C Burkhard D Schuler NM Probst-Hensch PC Maiorka N Baeza P Pisani Y Yonekawa MG Yasargil UM Lutolf P Kleihues, Cancer Res 2004 64 6892 6899 10.1158/0008-5472.CAN-04-1337 15466178
4. Radiotherpay plus concomitant and adjuvant temozolomide for glioblastoma. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group, N Engl J Med 2005 352 987 996 10.1056/NEJMoa043330 15758009
5. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. HL Fillmore TE VanMeter WC Broaddus, J Neuro-Oncol 2001 53 187 202 10.1023/A:1012213604731 (Pubitemid 33034691)
6. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. G Velasco S Cal A Merlos-Suarez AA Ferrando S Alvarez A Nakano J Arribas C Lopez-Otin, Cancer Res 2000 60 877 882 10706098
7. New functions for the matrix metalloproteinases in cancer progression. M Egeblad Z Werb, Nat Rev Cancer 2002 2 161 174 10.1038/nrc745 11990853
8. Structure and function of matrix metalloproteinases and TIMPs. H Nagase R Visse G Murphy, Cardiovasc Res 2006 69 562 573 10.1016/j.cardiores.2005.12.002 16405877
9. High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma. PA Forsyth T Dickinson-Laing AW Gibson NB Rewcastle P Brasher G Sutherland RN Johnston DR Edwards, J Neuro-Oncol 1998 36 21 29 10.1023/A:1005879027267 (Pubitemid 28230649)
10. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression. JH Hur MJ Park IC Park DH Yi CH Rhee SI Hong SH Lee, J Korean Med Sci 2000 15 309 314 10895974
11. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. K Lampert U Machein MR Machein W Conca HH Peter B Volk, Am J Pathol 1998 153 429 437 9708803
12. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. E Llano AM Pendas JP Freije A Nakano V Knauper G Murphy C Lopez-Otin, Cancer Res 1999 59 2570 2576 10363975
13. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. M Nakada H Nakamura E Ikeda N Fujimoto J Yamashita H Sato M Seiki Y Okada, Am J Pathol 1999 154 417 428 10027400 (Pubitemid 29094092)
14. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. T Nakagawa T Kubota M Kabuto K Sato H Kawano T Hayakawa Y Okada, J Neurosurg 1994 81 69 77 10.3171/jns.1994.81.1. 0069 8207529
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. A Nakano E Tani K Miyazaki Y Yamamoto J Furuyama, J Neurosurg 1995 83 298 307 10.3171/jns.1995.83.2.0298 7616276
16. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. J Stojic C Hagemann S Haas C Herbold S Kühnel S Gerngras W Roggendorf K Roosen GH Vince, Neurosci Res 2008 60 40 49 10.1016/j.neures.2007.09.009 17980449
17. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. JC Tonn S Kerkau A Hanke H Bouterfa JG Mueller S Wagner GH Vince K Roosen, Int J Cancer 1999 80 764 772 10.1002/(SICI)1097-0215(19990301)80:5<764::AID-IJC22>3.0.CO;2-J 10048980
18. Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. GH Vince S Wagner T Pietsch R Klein RH Goldbrunner K Roosen JC Tonn, Int J Dev Neurosci 1999 17 437 445 10.1016/S0736-5748(99)00018- 0 10571406
19. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. S Wagner C Stegen H Bouterfa C Huettner S Kerkau W Roggendorf K Roosen JC Tonn, J Neurooncol 1998 40 113 122 10.1023/A: 1006146405880 9892093
20. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. M Yamamoto S Mohanam R Sawaya GN Fuller M Seiki H Sato ZL Gokaslan LA Liotta GL Nicolson JS Rao, Cancer Res 1996 56 384 392 8542596
21. Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. O Engebraaten R Bjerkvig ME Berens, Cancer Res 1991 51 1713 1719 1998962
22. RAF expression in human astrocytic tumors. C Hagemann J Gloger J Anacker HM Said S Gerngras S Kühnel C Meyer UR Rapp U Kämmerer D Vordermark M Flentje K Roosen GH Vince, Int J Mol Med 2009 23 17 31 19082503
23. Proteins involved in cell migration from glioblastoma neurospheres analyzed by overexpression and siRNA-mediated knock-down. C Hagemann HM Said M Flentje K Roosen GH Vince, RNAi and micro RNA-mediated gene regulation in stem cells. Methods in Molecular Biology 650 New York, Dordrecht, heidelberg, London: The Humana Press Inc, Zhang B, Stellwag EJ, 2010 129 143 full-text
24. In vitro and in vivo models for the study of brain tumour invasion. GJ Pilkington R Bjerkvig L De Ridder P Kaaijk, Anticancer Res 1997 17 4107 4109 9428342
25. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. T Abe T Mori K Kohno M Seiki T Hayakawa HG Welgus S Hori M Kuwano, Clin Exp Metastasis 1994 12 296 304 10.1007/BF01753836 8039304
26. Microarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer. AV Chernov S Baranovskaya VS Golubkov DR Wakeman EY Snyder R Williams AY Strongin, J Biol Chem 2010 285 19647 19659 10.1074/jbc.M109.088153 20404328
27. Expression of matrix metalloproteinase-26 promotes human glioma U251 cell invasion in vitro and in vivo. Y Deng W Li H Yang H Xu S Liang L Zhang Y Li, Oncol Rep 2010 23 69 78 19956866
28. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. SY Kim SH Jung HS Kim, Biochem and Biophys Res Comm 2005 337 510 516 10.1016/j.bbrc.2005.09.079 (Pubitemid 41429314)
29. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. S Kondraganti S Mohanam SK Chintala Y Kin SL Jasti C Nirmala SS Lakka Y Adachi AP Kyritsis F Ali-Osman R Sawaya GN Fuller JS Rao, Cancer Res 2000 60 6851 6855 11156378
30. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell-line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. SS Lakka CS Gondi N Yanamandra WC Olivero DH Dinh M Gujrati JS Rao, Oncogene 2004 23 4681 4689 10.1038/sj.onc.1207616 15122332
31. Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. RK Nuttall CJ Pennington J Taplin A Wheal VW Yong PA Forsyth DR Edwards, Mol Cancer Res 2003 1 333 345 12651907
32. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. Ki Shofuda K Moriyama A Nishihashi S Higashi H Mizushima H Yasumitsu K Miki H Sato M Seiki K Miyazaki, J Biochem 1998 124 462 470 9685743
33. Glioma invasion in vitro: regulation by matrix metalloproteinase-2 and protein kinase C. JH Uhm NP Dooley JG Villemure VW Yong, Clin Exp Metastasis 1996 14 421 433 10.1007/BF00128958 8871536
34. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. TE Van Meter WC Broaddus HK Rooprai GJ Pilkington HL Fillmore, Neuro-Oncol 2004 6 188 199 10.1215/S1152851703000486 15279711
35. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. TE Van Meter HK Rooprai MM Kibble HL Fillmore WC Broaddus GJ Pilkington, J Neurooncol 2001 53 213 235 10.1023/A:1012280925031 11716072
36. Molecular determinants of glioma cell migration and invasion. C Wild-Bode M Weller W Wick, J Neurosurg 2001 94 978 984 10.3171/jns.2001.94.6.0978 11409528
37. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. O Kargiotis C Chetty CS Gondi AJ Tsung DH Dinh M Gujrati SS Lakka AP Kyritsis JS Rao, Oncogene 2008 27 4830 4840 10.1038/onc.2008.122 18438431
38. Proteases and glioma angiogenesis. SS Lakka CS Gondi JS Rao, Brain Pathol 2005 15 327 341 10.1111/j.1750-3639.2005.tb00118.x 16389945
39. Proteases in brain tumour progression. N Levicar RK Nutall TT Lah, Acta Neurochir 2003 145 825 838 10.1007/s00701-003-0097-z (Pubitemid 37204559)
40. The role of matrix metalloproteinases in glioma invasion. M Nakada Y Okada J Yamashita, Front Biosci 2003 8 261 e269 10.2741/1016 12456313
41. Inhibition of metalloproteinases derived from tumors: new insights in the treatment of human glioblastoma. P Gabelloni E Da Pozzo S Bendinelli B Costa E Nuti F Casalini E Orlandini F Da Settimo A Rossello C Martini, Neurosci 2010 168 514 522 10.1016/j.neuroscience.2010.03.064
42. Overview of matrix metalloproteinase expression in cultured human cells. TA Giambernardi GM Grant GP Taylor RJ Hay VM Maher JJ McCormick RJ Klebe, Matrix Biol 1998 16 483 496 10.1016/S0945-053X(98)90019-1 9550265
43. The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain-tumor cells. M Rossi HK Rooprai SL Maidment GJ Rucklidge GJ Pilkington, Anticancer Res 1996 16 121 128 8615596
44. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. D Trog K Yeghiazaryan M Fountoulakis A Friedlein H Moenkemann N Haertel H Schueller W Breipohl H Schild D Leppert O Golubnitschaja, Eur J Pharmacol 2006 542 8 15 10.1016/j.ejphar.2006.05.026 16806166
45. A MT1-MMP/NFB signaling axis as a checkpoint controller of COX-2 expression in CD133(+) U87 glioblastoma cells. B Annabi C Laflamme A Sina MP Lachambre R Béliveau, J Neuroinflammation 2009 6 8 10.1186/1742-2094-6-8 19272160
46. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. S Sarkar RK Nuttall S Liu DR Edwards VW Yong, Cancer Res 2006 66 11771 11780 10.1158/0008-5472.CAN-05-0470 17178873
47. MMP-7 (Matrilysin) expression in human brain tumors. C Rome J Arsaut C Taris F Couillaud H Loiseau, Mol Carcinogenesis 2007 46 446 452 10.1002/mc.20293 (Pubitemid 46897049)
48. Exploitation of astrocytes by glioma cells facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the Urokinase-type Plasminogen activator-plasmin cascade. DM Le A Besson DK Fogg KS Choi DM Waisman CG Goodyer B Rewcastle VW Yong, J Neurosci 2003 23 4034 4043 12764090
49. Silencing hypoxia-inducible factor-1 inhibits cell migration and invasion under hypoxic environment in malignant gliomas. S Fujiwara K Nakagawa H Harada S Nagato K Furukawa M Teraoka T Seno K Oka S Iwata T Ohnishi, Int J Oncol 2007 30 793 802 17332917
50. Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide. NA Pullen HL Fillmore, J Neurooncol 2010 96 201 209 10.1007/s11060-009-9965-6 19629394
51. IL-6 augments the invasivness of U87 human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. R Li G Li L Deng Q Liu J Dai J Shen J Zhang, Oncol Rep 2010 23 1553 1559 20428809
52. Mitogens as motogens. MR Chicoine DL Silbergeld, J Neuro-Oncol 1997 35 249 257 10.1023/A:1005808315821 (Pubitemid 27511129)
53. Malignant glioma biology: role for TGF- in growth, motility, angiogenesis, and immune escape. M Platten W Wick M Weller, Microscopy Res and Technique 2001 52 401 410 10.1002/1097-0029(20010215)52:4<401::AID- JEMT1025>3.0.CO;2-C
54. Glioma cell invasion: regulation of metalloproteinase activity by TGF- W Wick M Platten M Weller, J Neuro-Oncol 2001 53 177 185 10.1023/A:1012209518843 (Pubitemid 33034690)
55. Interferon- regulation of TNF-induced matrix metalloproteinase 3 expression and migration of human glioma T98G cells. SM Cheng B Xing JCB Li BKW Cheung ASY Lau, Int J Cancer 2007 121 1190 1196 10.1002/ijc.22729 17520672
56. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF- and IFN- H Qin JD Moellinger A Wells LJ Windsor Y Sun EN Benveniste, J Immunol 1998 161 6664 6673 9862695
57. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. PO Esteve P Tremblay M Houde Y St-Pierre R Mandeville, Biochim Biophys Acta 1998 1403 85 96 10.1016/S0167-4889(98)00020-2 9622599
58. Effects of transforming growth factor-beta1 on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. W Paulus I Baur C Huettner B Schmauer W Roggendorf H Schlingensiepen W Brysch, J Neuropathol Exp Neurol 1995 54 236 244 10.1097/00005072-199503000-00010 7876891
59. Characteristics of human and rat glioma cells grown in a defined medium. LA Akslen KJ Andersen R Bjerkvig, Anticancer Res 1988 8 797 803 3178168
60. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells. HK Rooprai GJ Rucklidge C Panou GJ Pilkington, Brit J Cancer 2000 82 52 55 10.1054/bjoc.1999.0876 10638966
61. GAPDH is not regulated in human glioblastoma under hypoxic conditions. HM Said C Hagemann J Stojic B Schömig GH Vince M Flentje K Roosen D Vordermark, BMC Molecular Biology 2007 8 55 10.1186/1471-2199-8-55 17597534